Literature DB >> 21789554

Innate immune cells in breast cancer--from villains to heroes?

Tim Kees1, Mikala Egeblad.   

Abstract

The innate immune system ensures effective protection against foreign pathogens and plays important roles in tissue remodeling. There are many types of innate immune cells, including monocytes, macrophages, dendritic cells, and granulocytes. Interestingly, these cells accumulate in most solid tumors, including those of the breast. There, they play a tumor-promoting role through secretion of growth and angiogenic factors, as well as immunosuppressive molecules. This is in strong contrast to the tumor-suppressing effects that innate immune cells exert in vitro upon proper activation. Therapeutic approaches have been developed with the aim of achieving similar suppressive activities in vivo. However, multiple factors in the tumor microenvironment, many of which are immunosuppressive, represent a major obstacle to effective treatment. Here, we discuss the potential of combating breast cancer through activation of the innate immune system, including possible strategies to enhance the success of immunotherapy.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21789554     DOI: 10.1007/s10911-011-9224-2

Source DB:  PubMed          Journal:  J Mammary Gland Biol Neoplasia        ISSN: 1083-3021            Impact factor:   2.673


  141 in total

Review 1.  Regulatory T cells: a new frontier in cancer immunotherapy.

Authors:  Brian G Barnett; Jens Rüter; Ilona Kryczek; Michael J Brumlik; Pui Joan Cheng; Benjamin J Daniel; George Coukos; Weiping Zou; Tyler J Curiel
Journal:  Adv Exp Med Biol       Date:  2008       Impact factor: 2.622

2.  CD40 ligation and phagocytosis differently affect the differentiation of monocytes into dendritic cells.

Authors:  Michelle Rosenzwajg; Frédéric Jourquin; Ludovic Tailleux; Jean Claude Gluckman
Journal:  J Leukoc Biol       Date:  2002-12       Impact factor: 4.962

3.  Tumor cytotoxicity of peritoneal macrophages and peripheral blood monocytes from patients with ovarian, endometrial, and cervical cancer.

Authors:  G. D. Wilbanks; M. -C. Ahn; D. A. Beck; D. P. Braun
Journal:  Int J Gynecol Cancer       Date:  1999-09       Impact factor: 3.437

4.  Cytosolic entry of bisphosphonate drugs requires acidification of vesicles after fluid-phase endocytosis.

Authors:  Keith Thompson; Michael J Rogers; Fraser P Coxon; Julie C Crockett
Journal:  Mol Pharmacol       Date:  2006-02-24       Impact factor: 4.436

Review 5.  When MAGE meets RING: insights into biological functions of MAGE proteins.

Authors:  Yue Feng; Jinlan Gao; Maojun Yang
Journal:  Protein Cell       Date:  2011-02-20       Impact factor: 14.870

6.  Prognostic value of tumor-infiltrating dendritic cells expressing CD83 in human breast carcinomas.

Authors:  Mitsuhiko Iwamoto; Hisashi Shinohara; Akiko Miyamoto; Masaaki Okuzawa; Hideaki Mabuchi; Takehiro Nohara; Goki Gon; Masao Toyoda; Nobuhiko Tanigawa
Journal:  Int J Cancer       Date:  2003-03-10       Impact factor: 7.396

7.  Visualizing stromal cell dynamics in different tumor microenvironments by spinning disk confocal microscopy.

Authors:  Mikala Egeblad; Andrew J Ewald; Hanne A Askautrud; Morgan L Truitt; Bryan E Welm; Emma Bainbridge; George Peeters; Matthew F Krummel; Zena Werb
Journal:  Dis Model Mech       Date:  2008-09-18       Impact factor: 5.758

8.  The yin-yang of tumor-associated neutrophils.

Authors:  Alberto Mantovani
Journal:  Cancer Cell       Date:  2009-09-08       Impact factor: 31.743

Review 9.  Following TRAIL's path in the immune system.

Authors:  Christina Falschlehner; Uta Schaefer; Henning Walczak
Journal:  Immunology       Date:  2009-06       Impact factor: 7.397

Review 10.  Requirement of macrophages and eosinophils and their cytokines/chemokines for mammary gland development.

Authors:  Valérie Gouon-Evans; Elaine Y Lin; Jeffrey W Pollard
Journal:  Breast Cancer Res       Date:  2002-06-25       Impact factor: 6.466

View more
  15 in total

1.  Higher circulating levels of chemokine CCL22 in patients with breast cancer: evaluation of the influences of tumor stage and chemokine gene polymorphism.

Authors:  A Jafarzadeh; H Fooladseresht; K Minaee; M R Bazrafshani; A Khosravimashizi; M Nemati; M Mohammadizadeh; M M Mohammadi; A Ghaderi
Journal:  Tumour Biol       Date:  2014-10-22

2.  Cross Cancer Genomic Investigation of Inflammation Pathway for Five Common Cancers: Lung, Ovary, Prostate, Breast, and Colorectal Cancer.

Authors:  Rayjean J Hung; Cornelia M Ulrich; Ellen L Goode; Yonathan Brhane; Kenneth Muir; Andrew T Chan; Loic Le Marchand; Joellen Schildkraut; John S Witte; Rosalind Eeles; Paolo Boffetta; Margaret R Spitz; Julia G Poirier; David N Rider; Brooke L Fridley; Zhihua Chen; Christopher Haiman; Fredrick Schumacher; Douglas F Easton; Maria Teresa Landi; Paul Brennan; Richard Houlston; David C Christiani; John K Field; Heike Bickeböller; Angela Risch; Zsofia Kote-Jarai; Fredrik Wiklund; Henrik Grönberg; Stephen Chanock; Sonja I Berndt; Peter Kraft; Sara Lindström; Ali Amin Al Olama; Honglin Song; Catherine Phelan; Nicholas Wentzensen; Ulrike Peters; Martha L Slattery; Thomas A Sellers; Graham Casey; Stephen B Gruber; David J Hunter; Christopher I Amos; Brian Henderson
Journal:  J Natl Cancer Inst       Date:  2015-08-29       Impact factor: 13.506

3.  Genetically determined inflammatory-response related cytokine and chemokine transcript profiles between mammary carcinoma resistant and susceptible rat strains.

Authors:  Bharat Devapatla; Jennifer Sanders; David J Samuelson
Journal:  Cytokine       Date:  2012-05-18       Impact factor: 3.861

Review 4.  Interactions of ion transporters and channels with cancer cell metabolism and the tumour microenvironment.

Authors:  Anne Poder Andersen; José M A Moreira; Stine Falsig Pedersen
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2014-02-03       Impact factor: 6.237

5.  Exosomes in Cancer Microenvironment and Beyond: have we Overlooked these Extracellular Messengers?

Authors:  Ruowen Ge; Evan Tan; Soheila Sharghi-Namini; Harry H Asada
Journal:  Cancer Microenviron       Date:  2012-05-15

6.  Monocytes and macrophages, implications for breast cancer migration and stem cell-like activity and treatment.

Authors:  Rebecca Ward; Andrew H Sims; Alexander Lee; Christina Lo; Luke Wynne; Humza Yusuf; Hannah Gregson; Michael P Lisanti; Federica Sotgia; Göran Landberg; Rebecca Lamb
Journal:  Oncotarget       Date:  2015-06-10

Review 7.  Cell volume regulation in epithelial physiology and cancer.

Authors:  Stine F Pedersen; Else K Hoffmann; Ivana Novak
Journal:  Front Physiol       Date:  2013-08-30       Impact factor: 4.566

8.  Macrophage-tumor cell interactions regulate the function of nitric oxide.

Authors:  Michal A Rahat; Bernhard Hemmerlein
Journal:  Front Physiol       Date:  2013-06-18       Impact factor: 4.566

9.  Matrix metalloproteinase 8 (collagenase 2) induces the expression of interleukins 6 and 8 in breast cancer cells.

Authors:  Sally Thirkettle; Julie Decock; Hugh Arnold; Caroline J Pennington; Diane M Jaworski; Dylan R Edwards
Journal:  J Biol Chem       Date:  2013-04-30       Impact factor: 5.157

10.  Il-6 signaling between ductal carcinoma in situ cells and carcinoma-associated fibroblasts mediates tumor cell growth and migration.

Authors:  Kingsley O Osuala; Mansoureh Sameni; Seema Shah; Neha Aggarwal; Michelle L Simonait; Omar E Franco; Yan Hong; Simon W Hayward; Fariba Behbod; Raymond R Mattingly; Bonnie F Sloane
Journal:  BMC Cancer       Date:  2015-08-13       Impact factor: 4.430

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.